Evidentic • Therapeutic Indications • Granulomatosis with polyangiitis and microscopic polyangiitis
Granulomatosis with polyangiitis is a rare condition that results from blood vesells inflammation in the nose, sinuses, throat, lungs, and kidneys. Formerly called Wegener’s granulomatosis, this disease belongs to a group of blood vessel diseases called vasculitis. It slows the flow of blood to some of the organs and the way that they work.
Showing all 9 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price | |
---|---|---|---|---|---|---|---|---|---|---|
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
05/2018 |
217,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
09/2018 |
217,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
12/2018 |
217,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
02/2019 |
217,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
02/2019 |
217,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
08/2019 |
217,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
12/2019 |
217,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
07/2021 |
250,00Â € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
yes |
2 mg |
2-8°C / -80°C |
02/2023 |
217,00Â € |
Let us know about your inquiry details and we’ll contact you shortly.